Table 1 Demographic and symptom characteristics of study population at the start of the trial
Variable | Placebo | Treatment |
|---|---|---|
Participants | 75 | 75 |
Sex (Female %) | 48 (64%) | 40 (53%) |
Age (years; mean ± SD) | 62.48 ± 13.70 | 64.55 ± 12.42 |
Weight (kg; mean ± SD) | 79.23 ± 22.47 | 78.53 ± 18.94 |
Day frequency ≥ 10 (n,%) | 57 (76%) | 50 (67%) |
Nocturia ≥2 (n,%) | 60 (80%) | 70 (93%) |
Urgency ≥2 (n,%) | 62 (83%) | 63 (84%) |
Urgency incontinence≥1 (n,%) | 33 (44%) | 32 (43%) |
Stress incontinence ≥1 (n,%) | 9 (12%) | 10 (13%) |
Any incontinence ≥1 (n,%) | 42 (56%) | 35 (47%) |
Only two symptoms (n,%) | 25 (30%) | 26 (35%) |
Only three symptoms (n,%) | 29 (39%) | 30 (30%) |
All four symptoms (n,%) | 21 (28%) | 19 (25%) |